Celgene Shells Out $7.2B For Receptos In A Big Bet On Autoimmune Disease
Celgene ($CELG) is trading $7.2 billion in cash for Receptos ($RCPT) and its Phase III autoimmune treatment, building on some [...]
Celgene ($CELG) is trading $7.2 billion in cash for Receptos ($RCPT) and its Phase III autoimmune treatment, building on some [...]